expanded

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACRSOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

BOSTON and ROLLE, Switzerland, April 28, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and global leader…

5 days ago
NeOnc Technologies Holdings, Inc. Executive Chairman,Amir Heshmatpour, Assumes Expanded Leadership Roleas Companys New PresidentNeOnc Technologies Holdings, Inc. Executive Chairman,Amir Heshmatpour, Assumes Expanded Leadership Roleas Companys New President

NeOnc Technologies Holdings, Inc. Executive Chairman,Amir Heshmatpour, Assumes Expanded Leadership Roleas Companys New President

April 10, 2025 08:05 ET  | Source: NeOnc Technologies Holdings, Inc. CALABASAS, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- NeOnc…

3 weeks ago
J.S. Held Celebrates Growing Expertise in Service to an Expanded Client BaseJ.S. Held Celebrates Growing Expertise in Service to an Expanded Client Base

J.S. Held Celebrates Growing Expertise in Service to an Expanded Client Base

JERICHO, N.Y., April 8, 2025 /PRNewswire/ -- Global consulting firm J.S. Held elevates hundreds of team members across multiple geographies…

4 weeks ago
Carbon to Unveil Expanded AO Suite, New Parts Retrieval Basket, and Industry-Shaping Innovations at IDS 2025Carbon to Unveil Expanded AO Suite, New Parts Retrieval Basket, and Industry-Shaping Innovations at IDS 2025

Carbon to Unveil Expanded AO Suite, New Parts Retrieval Basket, and Industry-Shaping Innovations at IDS 2025

New automation solutions and material advancements aim to streamline workflows and expand possibilities for dental labs COLOGNE, Germany, March 12,…

2 months ago

Kia EV4, PV5 and Concept EV2 Make Debuts at 2025 Kia EV Day as Embodiment of Expanded Global EV Strategy

Kia presents global EV strategy and new EV paradigm at 2025 Kia EV Day Kia reinforces electrification leadership and revitalizes…

2 months ago
TECNO Upgrades Universal Tone with Expanded Skin Tone Color Card for More Inclusive and Advanced Mobile ImagingTECNO Upgrades Universal Tone with Expanded Skin Tone Color Card for More Inclusive and Advanced Mobile Imaging

TECNO Upgrades Universal Tone with Expanded Skin Tone Color Card for More Inclusive and Advanced Mobile Imaging

TECNO advances its Universal Tone technology with a scientifically upgraded multi-skin tone color card now featuring 372 color patches and…

2 months ago
AMD Announces Expanded Consumer and Commercial AI PC Portfolio at CESAMD Announces Expanded Consumer and Commercial AI PC Portfolio at CES

AMD Announces Expanded Consumer and Commercial AI PC Portfolio at CES

— AMD Ryzen™ AI Max, AMD Ryzen™ AI 300 Series and AMD Ryzen™ 200 Series processors bring incredible performance for…

4 months ago
MulticoreWare Expands Its Footprint in Tamil Nadu with the Inauguration of an Expanded Office in CoimbatoreMulticoreWare Expands Its Footprint in Tamil Nadu with the Inauguration of an Expanded Office in Coimbatore

MulticoreWare Expands Its Footprint in Tamil Nadu with the Inauguration of an Expanded Office in Coimbatore

COIMBATORE, India, Dec. 10, 2024 /PRNewswire/ -- MulticoreWare, Inc., a global technology company offering software IP solutions & engineering services,…

5 months ago
Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)

Menarini Group Presents New and Expanded Data at the 2024 San Antonio Breast Cancer Symposium Reinforcing the Role of ORSERDU (Elacestrant) for Patients with ER+, HER2- Advanced or Metastatic Breast Cancer (mBC)

Real-world evidence bolsters the efficacy of ORSERDU for the treatment of patients with ER+/HER2- ESR1-mut advanced or mBC.Updated results of…

5 months ago
TerrAscend Appoints Lynn Gefen to Expanded Role of Chief People OfficerTerrAscend Appoints Lynn Gefen to Expanded Role of Chief People Officer

TerrAscend Appoints Lynn Gefen to Expanded Role of Chief People Officer

TORONTO, Nov. 26, 2024 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND, OTCQX: TSNDF), a leading North…

5 months ago